2-(4-Methoxybenzyl)phenyl6-O-(ethoxycarbonyl)-β-D-glucopyranoside

CAS : 408504-26-7

Ref. 3D-FM152924

Informations sur le produit

• Nom: 2-(4-Methoxybenzyl)phenyl6-O-(ethoxycarbonyl)-β-D-glucopyranoside
• Synonymes: 2-[(4-Methoxyphenyl)methyl]phenyl-beta-D-glucopyranoside-6-(ethyl carbonate), Gw 869682X, Loteprednola Etabonate, β-<span class="text-smallcaps">D</span>-Glucopyranoside, 2-[(4-methoxyphenyl)methyl]phenyl, 6-(ethyl carbonate), β-D-Glucopyranoside, 2-[(4-methoxyphenyl)methyl]phenyl, 6-(ethyl carbonate), Sergliflozin etabonate

Description

Canagliflozin is a type of antidiabetic agent that is used to treat patients with type 2 diabetes. This drug works by decreasing the reabsorption of glucose in the kidneys, which increases the excretion of glucose, and thus reduces blood sugar levels. Canagliflozin also lowers blood pressure and has been shown to reduce cholesterol levels. It is an inhibitor of SGLT-1, a transporter protein in the kidney that is responsible for renal glucose reabsorption. The use of canagliflozin has been studied in animal models, where it was found to significantly increase glomerular filtration rate (GFR) and decrease blood pressure. It is recommended that canagliflozin be taken together with other anti-diabetic medications, such as insulin or metformin, due to its potential side effects on GFR and blood pressure.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 448.46 g/mol
• Formule: C₂₃H₂₈O₉
• Degré de pureté: Min. 95%